Oncology Institute Stock Price Prediction

TOI Stock  USD 0.17  0.02  13.33%   
As of 26th of November 2024, the relative strength index (RSI) of Oncology Institute's share price is approaching 44. This usually implies that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Oncology Institute, making its price go up or down.

Oversold Vs Overbought

44

 
Oversold
 
Overbought
The successful prediction of Oncology Institute's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Oncology Institute, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Oncology Institute's stock price prediction:
Wall Street Target Price
2
Quarterly Revenue Growth
0.229
Using Oncology Institute hype-based prediction, you can estimate the value of Oncology Institute from the perspective of Oncology Institute response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Oncology Institute to buy its stock at a price that has no basis in reality. In that case, they are not buying Oncology because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Oncology Institute after-hype prediction price

    
  USD 0.15  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Oncology Institute Basic Forecasting Models to cross-verify your projections.
For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.
Intrinsic
Valuation
LowRealHigh
0.040.758.20
Details
1 Analysts
Consensus
LowTargetHigh
2.282.502.78
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.000.000.00
Details

Oncology Institute After-Hype Price Prediction Density Analysis

As far as predicting the price of Oncology Institute at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Oncology Institute or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Oncology Institute, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Oncology Institute Estimiated After-Hype Price Volatility

In the context of predicting Oncology Institute's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Oncology Institute's historical news coverage. Oncology Institute's after-hype downside and upside margins for the prediction period are 0.01 and 7.60, respectively. We have considered Oncology Institute's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.17
0.15
After-hype Price
7.60
Upside
Oncology Institute is out of control at this time. Analysis and calculation of next after-hype price of Oncology Institute is based on 3 months time horizon.

Oncology Institute Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Oncology Institute is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Oncology Institute backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Oncology Institute, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.83 
7.45
  0.02 
  0.10 
11 Events / Month
12 Events / Month
In about 11 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.17
0.15
11.76 
37,250  
Notes

Oncology Institute Hype Timeline

On the 26th of November Oncology Institute is traded for 0.17. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of -0.1. Oncology is estimated to decline in value after the next headline, with the price expected to drop to 0.15. The average volatility of media hype impact on the company price is over 100%. The price depreciation on the next news is expected to be -11.76%, whereas the daily expected return is at this time at -0.83%. The volatility of related hype on Oncology Institute is about 6208.33%, with the expected price after the next announcement by competition of 0.07. About 20.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.74. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Oncology Institute has Price/Earnings (P/E) ratio of 190.67. The entity recorded a loss per share of 0.77. The firm had not issued any dividends in recent years. Considering the 90-day investment horizon the next estimated press release will be in about 11 days.
Check out Oncology Institute Basic Forecasting Models to cross-verify your projections.
For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.

Oncology Institute Related Hype Analysis

Having access to credible news sources related to Oncology Institute's direct competition is more important than ever and may enhance your ability to predict Oncology Institute's future price movements. Getting to know how Oncology Institute's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Oncology Institute may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
RMYHYRamsay Health Care 0.00 0 per month 0.00 (0.13) 4.08 (4.57) 20.29 
MFCSFMedical Facilities 0.00 0 per month 1.53  0.05  3.97 (2.42) 7.33 
JNHMFJack Nathan Medical 0.00 0 per month 0.00  0.11  0.00  0.00  131.85 
MCIOFMCI Onehealth Technologies 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
FSNUYFresenius SE Co 0.00 0 per month 0.00 (0.15) 1.88 (1.95) 5.02 
CANOCano Health 0.00 0 per month 4.70  0.03  11.11 (9.77) 36.13 
LFSTLifestance Health Group 0.03 8 per month 1.61  0.1  3.94 (3.30) 11.88 
AGLagilon health(0.05)10 per month 0.00 (0.11) 9.62 (11.52) 45.03 
PNTGPennant Group(0.46)10 per month 0.00 (0.11) 4.12 (3.97) 12.42 
BKDBrookdale Senior Living 0.05 8 per month 0.00 (0.17) 3.10 (4.56) 21.81 
SGRYSurgery Partners 1.50 9 per month 0.00 (0.22) 3.72 (4.88) 17.97 
SEMSelect Medical Holdings(0.90)9 per month 1.73  0.01  2.92 (2.50) 14.58 
ENSGThe Ensign Group(13.99)10 per month 0.00 (0.1) 2.32 (2.11) 10.08 
MDMednax Inc(0.04)7 per month 1.48  0.09  3.63 (2.85) 27.59 
UHSUniversal Health Services 5.67 11 per month 0.00 (0.17) 2.22 (4.07) 14.88 
ADUSAddus HomeCare 3.64 10 per month 0.00 (0.15) 2.50 (2.48) 7.74 
EHCEncompass Health Corp 1.23 11 per month 0.88  0.04  1.73 (1.86) 9.75 
CCMConcord Medical Services(0.11)9 per month 0.00 (0.07) 10.40 (8.15) 41.12 
AMSAmerican Shared Hospital 0.05 9 per month 2.17 (0.03) 3.18 (2.47) 14.74 
SNDASonida Senior Living 1.11 7 per month 0.00 (0.07) 5.59 (4.77) 12.89 
JYNTThe Joint Corp(0.25)8 per month 2.37 (0.01) 5.29 (4.02) 15.39 

Oncology Institute Additional Predictive Modules

Most predictive techniques to examine Oncology price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Oncology using various technical indicators. When you analyze Oncology charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Oncology Institute Predictive Indicators

The successful prediction of Oncology Institute stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Oncology Institute, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Oncology Institute based on analysis of Oncology Institute hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Oncology Institute's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Oncology Institute's related companies.
 2023 2024 (projected)
Dividend Yield0.02650.0235
Price To Sales Ratio0.460.44

Story Coverage note for Oncology Institute

The number of cover stories for Oncology Institute depends on current market conditions and Oncology Institute's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Oncology Institute is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Oncology Institute's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Oncology Institute Short Properties

Oncology Institute's future price predictability will typically decrease when Oncology Institute's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Oncology Institute often depends not only on the future outlook of the potential Oncology Institute's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Oncology Institute's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding73.7 M
Cash And Short Term Investments82.9 M

Complementary Tools for Oncology Stock analysis

When running Oncology Institute's price analysis, check to measure Oncology Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncology Institute is operating at the current time. Most of Oncology Institute's value examination focuses on studying past and present price action to predict the probability of Oncology Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncology Institute's price. Additionally, you may evaluate how the addition of Oncology Institute to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Money Managers
Screen money managers from public funds and ETFs managed around the world
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges